CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

INC Research

Jonathan Shough, Chief Information Officer

Roadmap for Technology Investments

Jonathan Shough

Customer Focus


With increasing opportunities being pre­sented to us through our rapid IT growth, we have become better equipped to exam­ine our work processes. IT plays such an integral part of our overall work that we recognize its impact on our ability to dis­seminate information to our customers. A major focus for us has been to listen to what our customers are saying so that we can gauge exactly where our needs, solu­tions and focus should be. The ability to apply our technology solutions for each customer has resulted in more efficient clinical trials. Looking forward, we are examining how working in the cloud can help bolster an even higher level of cus­tomer delivery.


Organize Investments


Our commitment to patient safety and quality research remains of paramount importance. Making the appropriate in­vestments in technology will help to drive better integration, collaboration and au­tomation. We strive to deliver superior monitoring across all clinical operations and eliminate any complexities.


Partnering with Medidata Solutions


As a clinical research organization, our regulatory environment differs from that of other CIO’s, particularly when we part­ner with outside vendors. We have a very different set of rules under which we have to operate. As a result of our partnership with Medidata Solutions, we’ve recently had significant growth with our cloud capabilities. This part­nership resulted in INC Research becom­ing the first CRO to achieve accreditation for the Medidata Clinical Cloud in June 2013.  


Through this relationship, we can en­able a full suite of cloud-based technolo­gies in conjunction with our Trusted Pro­cess, a proprietary data-driven clinical trial management approach, allowing for greater data transparency and collabora­tion. Delivery of cost-efficient methods that optimize trials from design to data­base lock and give near real-time visibil­ity to the data that are critical to the suc­cessful running of trials.


A New Viewpoint


INC Research recognizes that analytics must be at the forefront of our operational work to enhance the decision making process. This entails disseminat­ing data to the ap­propriate people to ensure the discovery of comprehensive and accurate solu­tions.


One of the challenges, as we go global are the opportunities where redundant activities tend to creep in, it is important to eliminate those activities which are not value added


By enabling our constituents to access a single global interface, we can provide a horizontal viewpoint across the spectrum so that clinical de­cisions are better informed. This not only drives deeper analytics, it also creates a platform to make decisions more efficiently and maintain safety biometrics within clinical operations.


Globalizing Operations to Reduce Variability


Currently, the biggest IT challenge is time. From our perspective, the data we utilize may differ across regions outside of westernized culture. The obstacle here becomes how to drive high-quality ac­tionable data at the right time. This re­mains an area of focus for us to ensure we deliver services that result in high-quality data delivered at the time users require. Leveraging our Trusted Process, we make sure accurate decisions are reached local­ly, regionally and globally.


Service Provider Mod­el to Collaboration Model


As I stepped into the role of CIO, we set up a governance com­mittee to examine the business prac­tices across INC Research and to es­tablish a collaboration model to help drive technology decisions that is fully visible and inclusive. IT is now working closely with our global busi­ness leaders to work toward refining and crafting our future IT investments. We feel strongly this will result in better educated decisions regarding our technol­ogy stack and will eliminate wasted effort and duplication.


Key Listening Skills


An essential starting point to any dialogue is the ability to listen. That has been the focus of our governance committee, so we can truly comprehend where the business actually wants to go and how technol­ogy can help to generate these goals. We take time to understand the importance of the front-end operational processes and how they impact the back-end technol­ogy processes. We are currently updating and optimizing many of our technologies that will better enable us to deliver on our commitments to customers.


 


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cioviewpoint/roadmap-for-technology-investments-nwid-282.html